Epigenica
The company develops multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks, including histone modifications and DNA methylation. Its EpiFinder platform enables researchers to profile multiple epigenetic markers simultaneously from low amounts of input material such as plasma, serum, or tissue. These tools are designed for applications in biomedical research, drug discovery, and precision medicine.
Visit websiteSolna, Sweden
Healthtech
Biotechnology
Life Sciences
Diagnostics
Funding summary
- Total raised
- €1.9M
- Funding rounds
- 1
Investors in Epigenica
Investors on record for Epigenica. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Epigenica?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors